Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop.
Newman
John H
JH
Departments of Medicine, Nashville VA Medical Center (GRECC), and Vanderbilt University, Nashville, Tenn, USA.
Fanburg
Barry L
BL
Archer
Stephen L
SL
Badesch
David B
DB
Barst
Robyn J
RJ
Garcia
Joe G N
JG
Kao
Peter N
PN
Knowles
James A
JA
Loyd
James E
JE
McGoon
Michael D
MD
Morse
Jane H
JH
Nichols
William C
WC
Rabinovitch
Marlene
M
Rodman
David M
DM
Stevens
Troy
T
Tuder
Rubin M
RM
Voelkel
Norbert F
NF
Gail
Dorothy B
DB
D000328:Adult; D000818:Animals; D001120:Arginine / Q000627:therapeutic use; D052006:Bone Morphogenetic Protein Receptors, Type II; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005544:Forecasting; D020022:Genetic Predisposition to Disease; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006976:Hypertension, Pulmonary / Q000150:complications / Q000235:genetics / Q000401:mortality / Q000628:therapy; D008297:Male; D008954:Models, Biological; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015221:Potassium Channels / Q000502:physiology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D051381:Rats; D012106:Research / Q000639:trends; D015398:Signal Transduction
D004791:Enzyme Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D015221:Potassium Channels; D001120:Arginine; D017346:Protein Serine-Threonine Kinases; C498218:BMPR2 protein, human; C498220:Bmpr2 protein, rat; D052006:Bone Morphogenetic Protein Receptors, Type II; D010196:Pancreatic Elastase